(RTTNews) - Black Diamond Therapeutics, Inc. (BDTX) will host a webcast presentation on December 3, 2025, at 8:00 am ET to highlight results from its ongoing Phase 2 clinical trial of silevertinib in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results